Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,195.50 | 10.00 | 0.12% |
| CAC 40 | 7,935.74 | 54.37 | -0.68% |
| DAX 40 | 22,491.49 | 187.25 | -0.83% |
| Dow JONES (US) | 42,299.70 | 155.09 | -0.37% |
| FTSE 100 | 8,655.68 | 10.44 | -0.12% |
| HKSE | 23,426.60 | 152.20 | -0.65% |
| NASDAQ | 17,804.03 | 94.98 | -0.53% |
| Nikkei 225 | 37,120.33 | 679.64 | -1.80% |
| NZX 50 Index | 12,287.46 | 18.33 | -0.15% |
| S&P 500 | 5,693.31 | 18.89 | -0.33% |
| S&P/ASX 200 | 7,982.00 | 13.00 | 0.16% |
| SSE Composite Index | 3,351.31 | 22.44 | -0.67% |